Preferential dilation of recipient coronary arteries of the collateral circulation by intracoronary administration of nitroglycerin
M Fujita,
K Yamanishi,
M Inoko,
and
K Miwa
Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.
OBJECTIVES. The purpose of this study was to test the hypothesis that the sensitivity to nitroglycerin of collateral vessels and recipient arteries is greater than that of donor arteries of the collateral circulation. BACKGROUND. The collateral circulation responds vigorously to nitroglycerin. However, the mechanisms of the efficacy of nitroglycerin for improving collateral circulation are not fully elucidated. METHODS. The diameter of donor and recipient arteries of the collateral circulation was measured with a computer-assisted analysis system in eight patients with well developed collateral vessels. Coronary angiography was repeated before and after the intracoronary injection of 50 micrograms of nitroglycerin. RESULTS. After nitroglycerin, the mean diameter +/- SD of donor arteries increased to 1.61 +/- 0.53 from 1.29 +/- 0.39 mm (p < 0.01), whereas the diameter of recipient arteries increased to 1.59 +/- 0.50 from 1.10 +/- 0.49 mm (p < 0.01). The change in the diameter of recipient arteries was significantly greater than that of donor arteries (52.3 +/- 24.6% vs. 24.7 +/- 11.5%, p < 0.05). These changes induced by the intracoronary injection of nitroglycerin were accompanied by a decrease in pacing-induced ST segment depression (0.16 +/- 0.06 to 0.06 +/- 0.04 mV, p < 0.01), suggesting increased flow reserve through collateral channels. CONCLUSIONS. These findings indicate that the sensitivity to nitroglycerin of recipient arteries of the collateral circulation is significantly greater than that of donor arteries. This observation may explain the strong response of the collateral circulation to nitroglycerin in patients with functionally significant collateral channels.
This article has been cited by other articles:

|
 |

|
 |
 
M Fujita and K Tambara
Recent insights into human coronary collateral development
Heart,
March 1, 2004;
90(3):
246 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tadamura, M. Mamede, S. Kubo, H. Toyoda, M. Yamamuro, H. Iida, N. Tamaki, K. Nishimura, M. Komeda, and J. Konishi
The Effect of Nitroglycerin on Myocardial Blood Flow in Various Segments Characterized by Rest-Redistribution Thallium SPECT
J. Nucl. Med.,
May 1, 2003;
44(5):
745 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Klassen, J. H. Traverse, and R. J. Bache
Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production
Am J Physiol Heart Circ Physiol,
September 1, 1999;
277(3):
H918 - H923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Seiler, J. J. Piek, and R. A. M. van Liebergen
Intracoronary Doppler and Collateral Resistance Response
Circulation,
June 9, 1998;
97(22):
2281 - 2282.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. J. Piek, R. A. M. van Liebergen, K. T. Koch, R. J. de Winter, R. J. G. Peters, and G. K. David
Pharmacological Modulation of the Human Collateral Vascular Resistance in Acute and Chronic Coronary Occlusion Assessed by Intracoronary Blood Flow Velocity Analysis in an Angioplasty Model
Circulation,
July 1, 1997;
96(1):
106 - 115.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. L. Fallen, C. Nahmias, A. Scheffel, G. Coates, R. Beanlands, and E. S. Garnett
Redistribution of Myocardial Blood Flow With Topical Nitroglycerin in Patients With Coronary Artery Disease
Circulation,
March 1, 1995;
91(5):
1381 - 1388.
[Abstract]
[Full Text]
|
 |
|
|